High affinity receptors for vasoactive intestinal peptide on a human glioma cell line. 1990

F C Nielsen, and S Gammeltoft, and B Westermark, and J Fahrenkrug
Department of Clinical Chemistry, Bispebjerg Hospital, Copenhagen NV, Denmark.

Vasoactive intestinal peptide (VIP) bound with high affinity (Kd 0.13 nmol/l) to receptors on the human glioma cell line U-343 MG Cl 2:6. The receptors bound the related peptides helodermin, PHM and secretin with 10, 400 and 5000 times lower affinity, respectively. Deamidated VIP (VIP-COOH) and [des-His1]VIP bound with 10 and 100 times lower affinity. The fragment VIP(7-28) displaced 25% of the receptor-bound 125I-VIP whereas VIP(16-28) and VIP(1-22-NH2) were inactive. The binding of 125I-VIP could be completely inhibited by 10 mumol/l of the antagonists [N-Ac-Tyr1,D-Phe2]GRF(1-29)-NH2, [pCl-D-Phe6,Leu17]VIP and VIP(10-28); in contrast, the antagonist L-8-K was inactive. Affinity labeling showed that VIP bound to proteins with Mr's of 75 kDa, 66 kDa and 50 kDa, respectively. Following binding, the peptide was rapidly internalized, and at steady-state only 20% of cell-associated 125I-VIP was bound to receptors on the cell surface. The internalized 125I-VIP was completely degraded to 125I-tyrosine which was released from the cells. Degradation of internalized 125I-VIP was significantly reduced by chloroquine phenanthroline and pepstatin-A. Surface binding and internalization of 125I-VIP was increased 3 times by phenanthroline, and pepstatin-A caused a 5 times increase in surface binding. Chloroquine reduced surface-bound 125I-VIP, but caused retention of internalized 125I-VIP.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D008247 Lysosomes A class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of lysosomes depend on their lytic potential. The single unit membrane of the lysosome acts as a barrier between the enzymes enclosed in the lysosome and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured or undergoes MEMBRANE FUSION. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Autolysosome,Autolysosomes,Lysosome
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D011964 Receptors, Gastrointestinal Hormone Cell surface proteins that bind gastrointestinal hormones with high affinity and trigger intracellular changes influencing the behavior of cells. Most gastrointestinal hormones also act as neurotransmitters so these receptors are also present in the central and peripheral nervous systems. Gastrointestinal Hormone Receptors,Intestinal Hormone Receptors,Receptors, Gastrointestinal Peptides,Gastrointestinal Hormone Receptor,Intestinal Hormone Receptor,Receptors, Gastrointestinal Hormones,Receptors, Intestinal Hormone,Gastrointestinal Hormones Receptors,Gastrointestinal Peptides Receptors,Hormone Receptor, Gastrointestinal,Hormone Receptor, Intestinal,Hormone Receptors, Gastrointestinal,Hormone Receptors, Intestinal,Hormones Receptors, Gastrointestinal,Peptides Receptors, Gastrointestinal,Receptor, Gastrointestinal Hormone,Receptor, Intestinal Hormone
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D014660 Vasoactive Intestinal Peptide A highly basic, 28 amino acid neuropeptide released from intestinal mucosa. It has a wide range of biological actions affecting the cardiovascular, gastrointestinal, and respiratory systems and is neuroprotective. It binds special receptors (RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE). VIP (Vasoactive Intestinal Peptide),Vasoactive Intestinal Polypeptide,Vasointestinal Peptide,Intestinal Peptide, Vasoactive,Intestinal Polypeptide, Vasoactive,Peptide, Vasoactive Intestinal,Peptide, Vasointestinal,Polypeptide, Vasoactive Intestinal
D018005 Receptors, Vasoactive Intestinal Peptide Cell surface proteins that bind VASOACTIVE INTESTINAL PEPTIDE and PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE with high affinity and trigger intracellular changes which influence the behavior of cells. Receptors, VIP,VIP Receptors,Vasoactive Intestinal Peptide Receptors,VIP Receptor,Vasoactive Intestinal Peptide Receptor,Receptor, VIP

Related Publications

F C Nielsen, and S Gammeltoft, and B Westermark, and J Fahrenkrug
March 1989, Journal of immunology (Baltimore, Md. : 1950),
F C Nielsen, and S Gammeltoft, and B Westermark, and J Fahrenkrug
May 1989, Journal of immunology (Baltimore, Md. : 1950),
F C Nielsen, and S Gammeltoft, and B Westermark, and J Fahrenkrug
April 1994, Current eye research,
F C Nielsen, and S Gammeltoft, and B Westermark, and J Fahrenkrug
September 1989, The American journal of physiology,
F C Nielsen, and S Gammeltoft, and B Westermark, and J Fahrenkrug
July 1991, Regulatory peptides,
F C Nielsen, and S Gammeltoft, and B Westermark, and J Fahrenkrug
April 1984, Endocrinology,
F C Nielsen, and S Gammeltoft, and B Westermark, and J Fahrenkrug
January 1986, Peptides,
F C Nielsen, and S Gammeltoft, and B Westermark, and J Fahrenkrug
March 1990, Zhonghua yi xue za zhi,
F C Nielsen, and S Gammeltoft, and B Westermark, and J Fahrenkrug
May 1990, Experimental physiology,
F C Nielsen, and S Gammeltoft, and B Westermark, and J Fahrenkrug
June 1996, Blood,
Copied contents to your clipboard!